Download FREE Sample
Table of Contents
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Market Forecasting
- Executive Summary
- Market Overview
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Key Market Trends
- Industry Speaks
- Market Dynamics
- African Pharmaceutical Market - Size & Forecast (2021-2028), By Product Type
- Branded Drugs
- Generics
- Over-the-counter (OTC) Drugs
- African Pharmaceutical Market - Size & Forecast (2021-2028), By Therapy Areas
- Oncology
- Immunology
- Diabetes
- Cardiovascular
- Respiratory
- Central Nervous System (CNS)
- Others
- African Pharmaceutical Market - Size & Forecast (2021-2028), By End User
- Hospitals
- Clinics
- Others
- African Pharmaceutical Market - Size & Forecast (2021-2028), By Country/Region
- South Africa
- Algeria
- Nigeria
- Morocco
- Rest of Africa (Tunisia, Tanzania, Kenya, Ghana, and other African countries)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Competitive Positioning of Key Players (2022)
- Offerings Assessment, By Players
- Key Strategies Assessment, By Player (2021-2023)
- New Product & Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Key Companies Scanned (Indicative List)
- Adcock Ingram
- Aspen
- Hoffmann-La Roche
- Pfizer Inc.
- Novartis AG
- Cipla
- Johnson & Johnson (Janssen Global Services LLC)
- Merck and Co. Inc.
- Sanofi
- Other Key Players
